Maplight Therapeutics Inc (MPLT)
Maplight Therapeutics stock today
Maplight Therapeutics closed at $7.58 on October 30, 2026, down 1.81% on the day. Over the past year it returned -58.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $344 million.
| Period | MPLT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -25.6% | -0.9% |
| 3 months | -46.0% | +2.1% |
| Year to date | -56.8% | +11.7% |
| 1 year | -58.7% | +12.4% |
Key statistics
- Market value
- $344M
- 52-week range
- $7.58 to $39.80
- Next report
- Nov 12, 2026 (estimated)
About Maplight Therapeutics
Develops small molecule therapeutics for oncology and other diseases.
Sector: Health Care
More on Maplight Therapeutics
- Returns: what $1,000 became$1,000 one year ago is $412.63 today
No forecast, no recommendation. This page describes Maplight Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.